|
Dear Maryann,
It seems as thogh your oncologist might have missed all the recent news about herceptin and how indeed it improves survival rates dramatically for women without metastasis. I would get another opinion, and definitely push for the Herceptin. Read all the articles on this site about the clinical trials which were interrupted because Herceptin cut recurrence rates in half.
|